Skeletal muscle adaptations to interval training in patients with advanced COPD.
暂无分享,去创建一个
S. Zakynthinos | I. Vogiatzis | G. Terzis | O. Georgiadou | G. Stratakos | C. Roussos | D. C. Simoes | S. Nanas | D. Simoes | Serafeim Nanas
[1] L. Adams,et al. Continuous and intermittent exercise responses in individuals with chronic obstructive pulmonary disease , 2004, Thorax.
[2] I. Vogiatzis,et al. Dynamic hyperinflation and tolerance to interval exercise in patients with advanced COPD , 2004, European Respiratory Journal.
[3] N. Ambrosino,et al. New strategies to improve exercise tolerance in chronic obstructive pulmonary disease , 2004, European Respiratory Journal.
[4] F. Maltais,et al. Peripheral muscle endurance and the oxidative profile of the quadriceps in patients with COPD , 2004, Thorax.
[5] R. Henry,et al. Reduced mechanical efficiency in chronic obstructive pulmonary disease but normal peak VO2 with small muscle mass exercise. , 2004, American journal of respiratory and critical care medicine.
[6] C. Bouchard,et al. Human skeletal muscle fiber type alteration with high-intensity intermittent training , 2004, European Journal of Applied Physiology and Occupational Physiology.
[7] W. Stringer,et al. Training improves muscle oxidative capacity and oxygenation recovery kinetics in patients with chronic obstructive pulmonary disease , 2003, European Journal of Applied Physiology.
[8] I. Vogiatzis,et al. Interval training as an alternative modality to continuous exercise in patients with COPD , 2002, European Respiratory Journal.
[9] H. van Mameren,et al. Skeletal muscle fibre-type shifting and metabolic profile in patients with chronic obstructive pulmonary disease , 2002, European Respiratory Journal.
[10] E. Bozkanat,et al. Skeletal muscle dysfunction in chronic obstructive pulmonary disease , 2001, Respiratory research.
[11] R. Casaburi. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. , 1999, Medicine and science in sports and exercise.
[12] F. Maltais,et al. Oxidative enzyme activities of the vastus lateralis muscle and the functional status in patients with COPD , 2000, Thorax.
[13] J. Barberà,et al. Effects of endurance training on skeletal muscle bioenergetics in chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[14] F. Maltais,et al. Altered expression of myosin heavy chain in the vastus lateralis muscle in patients with COPD. , 1999, The European respiratory journal.
[15] D. Poole,et al. Evidence of skeletal muscle metabolic reserve during whole body exercise in patients with chronic obstructive pulmonary disease. , 1999, American journal of respiratory and critical care medicine.
[16] Chronic obstructive pulmonary disease: capillarity and fiber-type characteristics of skeletal muscle. , 1998, Journal of cardiopulmonary rehabilitation.
[17] F. Maltais,et al. Histochemical and morphological characteristics of the vastus lateralis muscle in patients with chronic obstructive pulmonary disease. , 1998, Medicine and science in sports and exercise.
[18] R. McKelvie,et al. Muscle performance and enzymatic adaptations to sprint interval training. , 1998, Journal of applied physiology.
[19] P. Śliwiński,et al. Reliability of inspiratory capacity for estimating end-expiratory lung volume changes during exercise in patients with chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.
[20] F. Maltais,et al. Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease. , 1997, American journal of respiratory and critical care medicine.
[21] F. Maltais,et al. Skeletal muscle adaptation to endurance training in patients with chronic obstructive pulmonary disease. , 1996, American journal of respiratory and critical care medicine.
[22] M. Decramer,et al. Peripheral muscle weakness contributes to exercise limitation in COPD. , 1996, American journal of respiratory and critical care medicine.
[23] F. Maltais,et al. Oxidative capacity of the skeletal muscle and lactic acid kinetics during exercise in normal subjects and in patients with COPD. , 1996, American journal of respiratory and critical care medicine.
[24] N. Jones,et al. Muscle strength, symptom intensity, and exercise capacity in patients with cardiorespiratory disorders. , 1995, American journal of respiratory and critical care medicine.
[25] L. Jorfeldt,et al. Metabolic enzyme activity in the quadriceps femoris muscle in patients with severe chronic obstructive pulmonary disease. , 1995, American journal of respiratory and critical care medicine.
[26] R. Casaburi,et al. Reductions in exercise lactic acidosis and ventilation as a result of exercise training in patients with obstructive lung disease. , 1991, The American review of respiratory disease.
[27] R. Casaburi,et al. Metabolic acidosis during exercise in patients with chronic obstructive pulmonary disease. Use of the V-slope method for anaerobic threshold determination. , 1988, Chest.
[28] M. Esbjörnsson,et al. Sprint training effects on muscle myoglobin, enzymes, fiber types, and blood lactate. , 1987, Medicine and science in sports and exercise.
[29] B. Saltin,et al. Skeletal Muscle Adaptability: Significance for Metabolism and Performance , 1985 .
[30] G. Borg. Psychophysical bases of perceived exertion. , 1982, Medicine and science in sports and exercise.
[31] B. Essén. Studies on the regulation of metabolism in human skeletal muscle using intermittent exercise as an experimental model. , 1978, Acta physiologica Scandinavica. Supplementum.
[32] M. Brooke,et al. Muscle fiber types: how many and what kind? , 1970, Archives of neurology.
[33] M. Brooke,et al. THREE "MYOSIN ADENOSINE TRIPHOSPHATASE" SYSTEMS: THE NATURE OF THEIR pH LABILITY AND SULFHYDRYL DEPENDENCE , 1970, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.
[34] P. Åstrand,et al. Textbook of Work Physiology , 1970 .
[35] L. Eriksen,et al. The ether soluble porphyrins found in the urine of normal man and rabbit. , 1962, Scandinavian journal of clinical and laboratory investigation.